The board of directors of JBM (Healthcare) Limited announced the appointment of Mr. Yu Chun Kau (Mr. Yu) as the company secretary and the authorised representative under Rule 3.05 of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited (of the Company in place of Mr. Lam Kau Lap (Mr. Lam) with effect from 23 November 2023. Mr. Lam will remain as the Vice President of Finance of the Company following his resignation as the Company Secretary and Authorised Representative. Mr. Yu, aged 51, is currently the Chief Financial Officer and company secretary of Jacobson Pharma Corporation Limited.

Mr. Yu possesses extensive experience in accounting, corporate finance, compliance and auditing. Mr. Yu graduated from The Chinese University of Hong Kong with a degree in bachelor of business administration with first class honours in December 1994. In June 2005, he also obtained a degree in master of corporate governance from The Open University of Hong Kong (currently known as Hong Kong Metropolitan University).

Mr. Yu was admitted as a fellow member of The Association of Chartered Certified Accountants in November 2002. He was admitted as a fellow member and was registered as a certified public accountant (practising) of the Hong Kong Institute of Certified Public Accountants (formerly known as Hong Kong Society of Accountants) in July 2005 and in October 2002, respectively. In March 2007, he was admitted as a senior international finance manager in the International Financial Management Association.

In April 2015, he was also admitted as a fellow member of The Institute of Chartered Accountants in England and Wales. In September 2016, he was admitted as both a fellow member of The Hong Kong Institute of Chartered Secretaries (currently known as The Hong Kong Chartered Governance Institute) and as a fellow member of The Institute of Chartered Secretaries and Administrators (currently known as The Chartered Governance Institute).